
|Videos|June 10, 2021
What To Know About Aducanumab and Slowing the Progression of Alzheimer Disease
Pharmacy Times spoke to Dr. Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.
Advertisement
Pharmacy Times spoke to Dr.Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Giredestrant Plus Everolimus Extends Survival in ER+, HER2- Advanced Breast Cancer
2
Nasal Vaccine Could Curb Whooping Cough Transmission and Boost Local Immunity
3
Higher-Dose Semaglutide Achieves Significant Weight Reduction in Adults with Obesity
4
Ethical Considerations of Artificial Intelligence Use Abound
5










































































































































































































